Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01468311||Active, not recruiting
|Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin s Lymphoma||
||6||All||18 Years to 99 Years (Adult, Senior)||NCT01468311||120003
|October 11, 2011||November 16, 2014||September 1, 2021||November 9, 2011||May 25, 2017||May 25, 2017||